Infographic: Biosimilar Substitution Laws By State

Article

Currently, 29 US states and Puerto Rico have passed laws allowing pharmacists to substitute biosimilars in place of a name-brand biologic drug. However, not all biosimilars laws are created alike: some require patients to be notified of the substitution, and some dictate that any substitutions must be for the lowest-cost drug.

To learn more about biosimilars legislation and which state could be next to pass such a law, see the infographic here.

Related Videos
Ha Kung Wong, JD
GBW 2023 webinar
Stephen Hanauer, MD, professor of medicine, Feinberg School of Medicine, Northwestern University,
Stephen Hanauer, MD, professor of medicine, Feinberg School of Medicine, Northwestern University,
 Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health.
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health
Michael Kleinrock
Michael Kleinrock
Ryan Haumschild, PharmD
Ryan Haumschild, PharmD, MS, MBA
Related Content
© 2024 MJH Life Sciences

All rights reserved.